# Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/ctad/123981) · 2026-11-20 · Medicine
Page: https://themorning.science/story/alzheimer-s-light-and-sound-stimulation-therapy-misses-main-goal-in-pivotal-tria-8037dfd4883ec1df
Kind: research · Impact: medium

## In brief

- A pivotal trial (HOPE) of an Alzheimer's therapy delivering 40 Hz light and sound stimulation did not meet its primary endpoint.
- The therapy was designed to engage gamma-frequency brain activity.
- The result was reported by MedPage Today from CTAD meeting coverage on 2026-11-20.

## Why it matters

A large pivotal trial failing its primary endpoint weakens the case for 40 Hz sensory stimulation as a treatment for Alzheimer's disease, and shapes how researchers and clinicians judge similar non-drug approaches.

## Timeline

- 2026-11-20: MedPage Today reports that the HOPE pivotal study missed its primary endpoint

## Coverage

- [Alzheimer's Light and Sound Stimulation Therapy Misses Main Goal in Pivotal Trial](https://www.medpagetoday.com/meetingcoverage/ctad/123981) — MedPageToday.com - medical news for physicians, 2026-11-20

Tags: alzheimers, clinical trial, gamma stimulation, neuroscience, dementia

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
